Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study by Hawarden, Amy et al.
CORRECTION Open Access
Correction to: Factors determining ultra-
short-term survival and the
commencement of active treatment in
high-grade serous ovarian cancer: a case
comparison study
Amy Hawarden1,2, Bryn Russell1, Mary Ellen Gee1,2, Fatima Kayali1, Andrew Clamp1,3, Emma Jayne Crosbie1,2 and
Richard John Edmondson1,2*
Correction to: BMC Cancer 21, 378 (2021)
https://doi.org/10.1186/s12885-021-08019-9
Following publication of the original article [1], the au-
thors identified an error in the author name of Fatima
Kayali.
The incorrect author name is: Fatima Skayali
The correct author name is: Fatima Kayali
The Contributions section has therefore also been up-
dated as follows:
RJE and AH devised the study, AH, MEG, & FK ex-
tracted data, AH & BR analysed data, AC & EJC pro-
vided interpretation and assisted writing the manuscript.
All authors have read and approved the manuscript.
The author group has been updated above and the ori-
ginal article [1] has been corrected.
Author details
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health,
Manchester Academic Health Science Centre, University of Manchester, St
Mary’s Hospital, Research Floor, Oxford Road, Manchester M13 9WL, UK.
2Department of Obstetrics and Gynaecology, Manchester Academic Health
Science Centre, St Mary’s Hospital, Central Manchester NHS Foundation Trust,
Manchester Academic Health Science Centre, Level 5, Research, Oxford Road,
Manchester, UK. 3Department of Medical Oncology, The Christie NHS
Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
Reference
1. Hawarden A, Russell B, Gee ME, Kayali F, Clamp A, Crosbie EJ, et al. Factors
determining ultra-short-term survival and the commencement of active
treatment in high-grade serous ovarian cancer: a case comparison study.
BMC Cancer. 2021;21(1):378. https://doi.org/10.1186/s12885-021-08019-9.
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
The original article can be found online at https://doi.org/10.1186/s12885-
021-08019-9.
* Correspondence: richard.edmondson@manchester.ac.uk
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health,
Manchester Academic Health Science Centre, University of Manchester, St
Mary’s Hospital, Research Floor, Oxford Road, Manchester M13 9WL, UK
2Department of Obstetrics and Gynaecology, Manchester Academic Health
Science Centre, St Mary’s Hospital, Central Manchester NHS Foundation Trust,
Manchester Academic Health Science Centre, Level 5, Research, Oxford Road,
Manchester, UK
Hawarden et al. BMC Cancer          (2021) 21:614 
https://doi.org/10.1186/s12885-021-08369-4
